Ignalinos veterinarinė vaistinė, UAB - financials and debts
Company age: 32 y. 5 mo.
Ignalinos veterinarinė vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 119,894 | 118,881 | 131,100 | 172,739 | 173,402 | 179,195 | 175,405 | 208,985 |
| Profit before tax | 8,366 | -4,327 | 17,215 | 5,421 | -1,997 | -9,297 | -1,424 | 3,371 |
| Net profit | 7,111 | -4,327 | 16,571 | 5,150 | -1,997 | -9,297 | -1,424 | 3,371 |
| Equity | 24,632 | 20,584 | 37,156 | 37,012 | 39,045 | 29,701 | 28,271 | 31,641 |
| Liabilities | 23,019 | 26,137 | 16,195 | 24,843 | 26,055 | 22,037 | 16,619 | 10,945 |
| Non-current assets | 27,509 | 29,362 | 27,033 | 28,772 | 28,201 | 21,138 | 15,061 | 10,960 |
| Current assets | 20,142 | 17,359 | 26,318 | 33,083 | 36,899 | 30,600 | 29,829 | 31,626 |
| Total assets | 47,651 | 46,721 | 53,351 | 61,855 | 65,100 | 51,738 | 44,890 | 42,586 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 23,985 | 20,560 | 25,625 |
| Social insurance contributions | - | - | - | - | - | 14,106 | 12,497 | 14,296 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -1.0% | -0.8% | +10.3% | +31.8% | +0.4% | +3.3% | -2.1% | +19.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 14.9% | -9.3% | 31.1% | 8.3% | -3.1% | -18.0% | -3.2% | 7.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 28.9% | -21.0% | 44.6% | 13.9% | -5.1% | -31.3% | -5.0% | 10.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.9% | -3.6% | 12.6% | 3.0% | -1.2% | -5.2% | -0.8% | 1.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.0% | -3.6% | 13.1% | 3.1% | -1.2% | -5.2% | -0.8% | 1.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.9 | 1.3 | 0.4 | 0.7 | 0.7 | 0.7 | 0.6 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 22,480 | 19,814 | 22,158 | 27,638 | 22,866 | 23,630 | 32,889 | 35,321 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ignalinos veterinarinė vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-12-18 | 2023-12-19 | 76.25 |
Ignalinos veterinarinė vaistinė - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ignalinos veterinarine vaistine, UAB (code 155549469) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €209.0K, up 19.1% year on year and 16.6% over two years. Net profit for 2025 was €3.4K, compared with a loss of €1.4K in 2024 and a larger loss of €9.3K in 2023, indicating a clear return to profitability. The 2025 profit margin was 1.6%. The balance sheet remained solid, with total assets of €42.6K, equity of €31.6K and liabilities of €10.9K. The equity ratio stood at 74.3% and debt-to-equity at 0.35, suggesting a conservative financial structure. Asset turnover was 4.91x, reflecting efficient use of assets in relation to revenue. Revenue per employee was €41.8K and profit per employee was €674. Overall, 2025 shows higher sales, improved earnings and a stronger financial position than in the previous two years.